USE OF DL-(+/-)-.ALPHA.-LIPOIC ACID, D-(+)-.ALPHA.-LIPOIC ACID, .ALPHA.-LIPOIC ACID IN REDUCED OR OXIDIZED FORM OR SALTS FOR TREATING CIRCULATORY DISORDERS

USE OF DL-(+/-)-.ALPHA.-LIPOIC ACID, D-(+)-.ALPHA.-LIPOIC ACID, .ALPHA.-LIPOIC ACID IN REDUCED OR OXIDIZED FORM OR SALTS FOR TREATING CIRCULATORY DISORDERS

The invention relates to the use of DL-(+/-)-.alpha. lipoic acid, D(+)-.alpha.-lipoic acid, L-(-)-.alpha.-lipoic acid in reduced or oxidised form or of the metabolites and salts, esters, amides thereof for the preparation of medicines for the treatment of disorders caused by changes or disturbances...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CONRAD, FRANK, HENRICH, HERMANN-AUGUST, GEISE, WOLFGANG, ULRICH, HEINZ
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CONRAD, FRANK
HENRICH, HERMANN-AUGUST
GEISE, WOLFGANG
ULRICH, HEINZ
description The invention relates to the use of DL-(+/-)-.alpha. lipoic acid, D(+)-.alpha.-lipoic acid, L-(-)-.alpha.-lipoic acid in reduced or oxidised form or of the metabolites and salts, esters, amides thereof for the preparation of medicines for the treatment of disorders caused by changes or disturbances in the rheological properties of the blood such as blood viscosity, erythrocyte flexibility and the aggregation of erythrocytes, in particular for the treatment of microangiopathy with disturbed microcirculation. It can be used in particular in the treatment of diabetics and of dialysis patients for protection of the erythrocytes, in central and peripheral circulatory disturbances and in tinnitus and hearing loss.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2521133C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2521133C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2521133C3</originalsourceid><addsrcrecordid>eNqFikEKwjAQRbtxIeoZnKWiqbTFA4RMageiKZMU1E0pEleihXobL2sLLhVX___3_jh6VU6DzQGNWKw2YiliacpCxsJQaUmBVIRrwF7-UF8g0AFYY6U0gmWwR0I69z23vB-Ak8a7YYFnLT0ddqCIVWWkt3wCJGcZNbtpNLo2ty7MPjmJ5rn2qhChfdSha5tLuIdnrWS6TZMky1T2__EG7Mw_9Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF DL-(+/-)-.ALPHA.-LIPOIC ACID, D-(+)-.ALPHA.-LIPOIC ACID, .ALPHA.-LIPOIC ACID IN REDUCED OR OXIDIZED FORM OR SALTS FOR TREATING CIRCULATORY DISORDERS</title><source>esp@cenet</source><creator>CONRAD, FRANK ; HENRICH, HERMANN-AUGUST ; GEISE, WOLFGANG ; ULRICH, HEINZ</creator><creatorcontrib>CONRAD, FRANK ; HENRICH, HERMANN-AUGUST ; GEISE, WOLFGANG ; ULRICH, HEINZ</creatorcontrib><description>The invention relates to the use of DL-(+/-)-.alpha. lipoic acid, D(+)-.alpha.-lipoic acid, L-(-)-.alpha.-lipoic acid in reduced or oxidised form or of the metabolites and salts, esters, amides thereof for the preparation of medicines for the treatment of disorders caused by changes or disturbances in the rheological properties of the blood such as blood viscosity, erythrocyte flexibility and the aggregation of erythrocytes, in particular for the treatment of microangiopathy with disturbed microcirculation. It can be used in particular in the treatment of diabetics and of dialysis patients for protection of the erythrocytes, in central and peripheral circulatory disturbances and in tinnitus and hearing loss.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090714&amp;DB=EPODOC&amp;CC=CA&amp;NR=2521133C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090714&amp;DB=EPODOC&amp;CC=CA&amp;NR=2521133C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CONRAD, FRANK</creatorcontrib><creatorcontrib>HENRICH, HERMANN-AUGUST</creatorcontrib><creatorcontrib>GEISE, WOLFGANG</creatorcontrib><creatorcontrib>ULRICH, HEINZ</creatorcontrib><title>USE OF DL-(+/-)-.ALPHA.-LIPOIC ACID, D-(+)-.ALPHA.-LIPOIC ACID, .ALPHA.-LIPOIC ACID IN REDUCED OR OXIDIZED FORM OR SALTS FOR TREATING CIRCULATORY DISORDERS</title><description>The invention relates to the use of DL-(+/-)-.alpha. lipoic acid, D(+)-.alpha.-lipoic acid, L-(-)-.alpha.-lipoic acid in reduced or oxidised form or of the metabolites and salts, esters, amides thereof for the preparation of medicines for the treatment of disorders caused by changes or disturbances in the rheological properties of the blood such as blood viscosity, erythrocyte flexibility and the aggregation of erythrocytes, in particular for the treatment of microangiopathy with disturbed microcirculation. It can be used in particular in the treatment of diabetics and of dialysis patients for protection of the erythrocytes, in central and peripheral circulatory disturbances and in tinnitus and hearing loss.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFikEKwjAQRbtxIeoZnKWiqbTFA4RMageiKZMU1E0pEleihXobL2sLLhVX___3_jh6VU6DzQGNWKw2YiliacpCxsJQaUmBVIRrwF7-UF8g0AFYY6U0gmWwR0I69z23vB-Ak8a7YYFnLT0ddqCIVWWkt3wCJGcZNbtpNLo2ty7MPjmJ5rn2qhChfdSha5tLuIdnrWS6TZMky1T2__EG7Mw_9Q</recordid><startdate>20090714</startdate><enddate>20090714</enddate><creator>CONRAD, FRANK</creator><creator>HENRICH, HERMANN-AUGUST</creator><creator>GEISE, WOLFGANG</creator><creator>ULRICH, HEINZ</creator><scope>EVB</scope></search><sort><creationdate>20090714</creationdate><title>USE OF DL-(+/-)-.ALPHA.-LIPOIC ACID, D-(+)-.ALPHA.-LIPOIC ACID, .ALPHA.-LIPOIC ACID IN REDUCED OR OXIDIZED FORM OR SALTS FOR TREATING CIRCULATORY DISORDERS</title><author>CONRAD, FRANK ; HENRICH, HERMANN-AUGUST ; GEISE, WOLFGANG ; ULRICH, HEINZ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2521133C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2009</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CONRAD, FRANK</creatorcontrib><creatorcontrib>HENRICH, HERMANN-AUGUST</creatorcontrib><creatorcontrib>GEISE, WOLFGANG</creatorcontrib><creatorcontrib>ULRICH, HEINZ</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CONRAD, FRANK</au><au>HENRICH, HERMANN-AUGUST</au><au>GEISE, WOLFGANG</au><au>ULRICH, HEINZ</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF DL-(+/-)-.ALPHA.-LIPOIC ACID, D-(+)-.ALPHA.-LIPOIC ACID, .ALPHA.-LIPOIC ACID IN REDUCED OR OXIDIZED FORM OR SALTS FOR TREATING CIRCULATORY DISORDERS</title><date>2009-07-14</date><risdate>2009</risdate><abstract>The invention relates to the use of DL-(+/-)-.alpha. lipoic acid, D(+)-.alpha.-lipoic acid, L-(-)-.alpha.-lipoic acid in reduced or oxidised form or of the metabolites and salts, esters, amides thereof for the preparation of medicines for the treatment of disorders caused by changes or disturbances in the rheological properties of the blood such as blood viscosity, erythrocyte flexibility and the aggregation of erythrocytes, in particular for the treatment of microangiopathy with disturbed microcirculation. It can be used in particular in the treatment of diabetics and of dialysis patients for protection of the erythrocytes, in central and peripheral circulatory disturbances and in tinnitus and hearing loss.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2521133C
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title USE OF DL-(+/-)-.ALPHA.-LIPOIC ACID, D-(+)-.ALPHA.-LIPOIC ACID, .ALPHA.-LIPOIC ACID IN REDUCED OR OXIDIZED FORM OR SALTS FOR TREATING CIRCULATORY DISORDERS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T09%3A30%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CONRAD,%20FRANK&rft.date=2009-07-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2521133C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true